Collaborative Publications

(2025 Infect Dis Rep) PH 22 Fungal Infections_Underexplored Pathological Links (40700330)

July 12, 2025

Pulmonary Hypertension Secondary to Fungal Infections: Underexplored Pathological Links

(2025 Infect Dis Rep) Gut Microbiome in PAH-An Emerging Frontier (40559197)

June 9, 2025

Gut Microbiome in Pulmonary Arterial Hypertension—An Emerging Frontier

(2025 Infect Dis Rep) Diff Effects of HIV Nef Variants on PV EC Dysfunction (40559196)

June 6, 2025

Differential Effects of Human Immunodeficiency Virus Nef Variants on Pulmonary Vascular Endothelial Cell Dysfunction

(2025 Infect Dis Rep) Global Landscape of Infection-Induced PH (40277962)

April 17, 2025

Global Landscape of Infection-Induced Pulmonary Hypertension

March 4, 2025

Clinical, Functional, and Hemodynamic Profile of Schistosomiasis-Associated Pulmonary Arterial Hypertension Patients in Brazil: Systematic Review and Meta-Analysis

(2025 Infect Dis Rep) Endothel Dysfunct Markers Corr w Time Since Completion of TB Tx (40126327)

February 28, 2025

Endothelial Dysfunction Markers Correlate with the Time Since Completion of Tuberculosis Treatment and the Number of Previous Tuberculosis Episodes

(2025 Infect Dis Rep) COVID-19 and Parasitic Co-Infection_Link to PVD (40126325)

February 27, 2025

COVID-19 and Parasitic Co-Infection: A Hypothetical Link to Pulmonary Vascular Disease

(2025 Infect Dis Rep) Genetics of Long COVID_Molecular Drivers of Persistent PVD Symptoms (39997467)

February 2, 2025

Genetics of Long COVID: Exploring the Molecular Drivers of Persistent Pulmonary Vascular Disease Symptoms

(2025 Infect Dis Rep) Early Use of Liraglutide for the Acute COVID-19 Infection_Phase II (39846709)

January 2, 2025

Early Use of Liraglutide for the Treatment of Acute COVID-19 Infection: An Open-Label Single-Center Phase II Safety Study with Biomarker Profiling

Screenshot-05-10-2023-224129

January 12, 2023

Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: Multilayered cross-talks in the setting of coinfections and comorbidities

Screenshot-05-10-2023-224328

November 30, 2022

Cardiopulmonary disease as sequelae of long-term COVID-19: Current perspectives and challenges

Screenshot 05-10-2023 223407

May 25, 2022

Potential long- term effects of SARS- CoV-2 infection on the pulmonary vasculature: a global perspective

Screenshot-06-10-2023-172320

October 6, 2018

Infection in pulmonary vasculardiseases: Would another consortiumreally be the way to go?